Latest News

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

PHILADELPHIA, PA – (BUSINESS WIRE) – November 27, 2023 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been acquired by ARCHIMED as an integral part of the company’s mission to enable clients to bring their life enhancing products to market faster.

Instem Announces New Software Solution to Support Updated Nitrosamines Guidance

September 28, 2023 - New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)

Instem Announces Transfer of ToxHub Platform and launch of Centrus®

May 15, 2023 - New powerful technology and data sharing suite provides a range of translational science solutions

Instem Unveils New Additions to its Leading Computational Toxicology Software Suite

November 2, 2022 - New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

Instem Awarded EMA Research Grant

May 10, 2022 - Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

View all news





Proud to be Presenting at Extractables & Leachables Summit

January 17 - 19, 2024

Virtual Conference

Visit Conference Site

'Applications of computational methods in the assessment of extractables and leachables'
Dr. Candice Johnson, Senior Research Scientist

Exhibiting at the 40th Annual Meeting of the Japanese Society of Toxicologic Pathology

January 23 - 24, 2024

Curian (Shinagawa General Citizen's Hall), Tokyo, Japan

Visit Conference Site

Solution Areas: Preclinical Study Management, SEND


View all events